HOME > Investors > Press Releases
2009-07-21
ViroMed Receives US FDA Approval of Phase II Trial for VM202 to Treat Peripheral Artery Disease
2009-06-09
Completion of Injections for China VM202 Phase I Trial
2009-03-06
ViroMed Receives Approval for Diabetic Neuropathy Phase I/II Trial
2009-03-04
ViroMed Receives Approval from US FDA for Phase I/II Trial for Diabetic Neuropathy
2008-12-03
[Pharmaceutical Business Review] ViroMed launches joint study with Biologics Delivery Systems
11 12 13 14 15 16 17 18 19 20